| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.099 | 0.04 |